Publikationen

2015

Fehse, K., Maikowski, L., Simmank, F., Gutyrchik, E., & Meissner, K. (2015).  Placebo Responses to Original vs Generic ASA Brands During Exposure to Noxious Heat: A Pilot fMRI Study of Neurofunctional Correlates. Pain Medicine. 16(10), 1967-1974.
Fässler, M., Meissner, K., Kleijnen, J., Hróbjartsson, A., & Linde, K. (2015).  A systematic review found no consistent difference in effect between more and less intensive placebo interventions. Journal of Clinical Epidemiology. 68(4), 442-451.
Heisig, S. R., Shedden-Mora, M. C., von Blanckenburg, P., Schuricht, F., Rief, W., Albert, U-S., et al. (2015).  Informing women with breast cancer about endocrine therapy: Effects on patients’ satisfaction, knowledge and adherence. Psycho-Oncology. 24(2), 130-137.
Heisig, S. R., Shedden-Mora, M. C., Hidalgo, P., & Nestoriuc, Y. (2015).  Framing and Personalizing Informed Consent to Prevent Negative Expectations: An Experimental Pilot Study. Health Psychology. 34(10), 1033-1037.
Jonas, W. B., Crawford, C., Colloca, L., Kaptchuk, T. J., Moseley, B., Miller, F. G., et al. (2015).  To what extent are surgery and invasive procedures effective beyond a placebo response? A systematic review with meta-analysis of randomised, sham controlled trials. BMJ Open. 5(12), e009655.
Klinger, R. (2015).  Exploiting placebo and nocebo effects in patients with chronic pain. Deutsche Medizinische Wochenschrift. 140(21), 1630-1632.
Laferton, J. A. C., Auer, C. J., Shedden-Mora, M. C., Moosdorf, R., & Rief, W. (2015).  Optimizing preoperative expectations in cardiac surgery patients ismoderated by level of disability: the successful development of abrief psychological intervention. Psychology, Health and Medicine.
Meissner, K. (2015).  How the Placebo works. An overview on the current state of Placebo research. Pädiatrische Praxis. 83(4), 551-560.
Nestoriuc, Y. (2015).  Risiken und Nebenwirkungen psychotherapeutischer Behandlung. Wie und warum sollten sie erfasst werden?. Psychotherapie im Dialog. 16(4), 36-40.
Rief, W., Glombiewski, J. A., Gollwitzer, M., Schubö, A., Schwarting, R., & Thorwart, A. (2015).  Expectancies as core features of mental disorders. Current opinion in psychiatry. 28(5), 378-385.
Schedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015).  Neuro-Bio-Behavioral Mechanisms of Placebo and Nocebo Responses: Implications for Clinical Trials and Clinical Practice. Pharmacol Rev. 67(3), 697-730.
Schmid, J., Langhorst, J., Gaß, F., Theyson, N., Benson, S., Engler, H., et al. (2015).  Placebo analgesia in patients with functional and organic abdominal pain: a fMRI study in IBS, UC and healthy volunteers. Gut. 64(3), 418-427.
Schmid, J., Bingel, U., Ritter, C., Benson, S., Schedlowski, M., Gramsch, C., et al. (2015).  Neural underpinnings of nocebo hyperalgesia in visceral pain: A fMRI study in healthy volunteers. Neuroimage. 120, 114-122.
Weimer, K., Colloca, L., & Enck, P. (2015).  Placebo effects in psychiatry: mediators and moderators. Lancet Psychiatry. 2(3), 246-257.
Winkler, A., & Rief, W. (2015).  Effect of placebo conditions on polysomnographic parameters in primary insomnia: a meta-analysis. SLEEP. 38(6), 925-931.
Zimmermann-Viehoff, F., Steckhan, N., Meissner, K., Deter, H-C., & Kirschbaum, C. (2015).  Influence of a Suggestive Placebo Intervention on Psychobiological Responses to Social Stress: A Randomized Controlled Trial. Journal of Evidence-Based Complementary & Alternative Medicine. 21(1), 3-9.
von Blanckenburg, P., Schuricht, F., Heisig, S. R., Shedden-Mora, M. C., Rehahn-Sommer, S., Albert, U-S., et al. (2015).  Psychologische Optimierung von Erwartungen zur Prävention von Nocebo-Nebenwirkungen bei Brustkrebs - 2 Fallberichte. Verhaltenstherapie. 25, 219-227.

2014

Albring, A., Wendt, L., Benson, S., Nissen, S., Yavuz, Z., Engler, H., et al. (2014).  Preserving learned immunosuppressive placebo response: Perspectives for clinical application. Clinical Pharmacology & Therapeutics. 96(2), 247-255.
Albring, A., Wendt, L., Harz, N., Engler, H., Wilde, B., Witzke, O., et al. (2014).  Short-term treatment with the calcineurin inhibitor cyclosporine A decreases HPA axis activity and plasma noradrenaline levels in healthy male volunteers. Pharmacology, Biochemistry and Behavior. 126, 73-76.
Bingel, U. (2014).  Avoiding Nocebo Effects to Optimize Treatment Outcome. The Journal of the American Medical Association. 312(7), 693-694.
Büchel, C., Geuter, S., Sprenger, C., & Eippert, F. (2014).  Placebo analgesia: A predictive coding perspective. Neuron. 81(6), 1223-1239.
Doering, B. K., Rief, W., & Petrie, K. J. (2014).  Lessons to be Learned from Placebo Arms in Psychopharmacology Trials. Handbook of experimental pharmacology. 225, 273-290.
Elsenbruch, S. (2014).  How positive and negative expectations shape the experience of visceral pain. Handbook of Experimental Pharmacology. 225, 97-119.
Heisig, S. R., Shedden-Mora, M. C., & Nestoriuc, Y. (2014).  Coping with medical information is related to Nocebo side effects in patients with breast cancer. Oncology Research and Treatment. 37(Suppl 1), 109.
Heisig, S. R., Shedden-Mora, M. C., von Blanckenburg, P., Schuricht, F., Rief, W., Albert, U. - S., et al. (2014).  Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence. Psycho-Oncology. 24(2), 130-137.

Pages